c-Jun N-terminal kinase mediates AML1-ETO protein-induced connexin-43 expression

被引:38
作者
Gao, Feng-Hou [1 ]
Wang, Qiong [1 ]
Wu, Ying-Li [1 ]
Li, Xi [1 ]
Zhao, Ke-Wen [1 ]
Chen, Guo-Qiang [1 ]
机构
[1] Shanghai Jiao Tong Univ, Rui Jin Hosp, Sch Med,Natl Minist Educ, Dept Pathophysiol,Key Lab Cell Differentiat & Apo, Shanghai 200025, Peoples R China
基金
中国国家自然科学基金;
关键词
AML1-ETO; connexin-43; leukemia; c-jun N-terminal kinase (JNK);
D O I
10.1016/j.bbrc.2007.03.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
AML1-ETO fusion protein, a product of leukemia-related chromosomal translocation t(8;2 1), was reported to upregulate expression of connexin-43 (Cx43), a member of gap junction-constituted connexin family. However, its mechanism(s) remains unclear. By bioinformatic analysis, here we showed that there are two putative AML1-binding consensus sequences followed by two activated protein (AP) I sites in the 5 '-flanking region upstream to Cx43 gene. AML1-ETO could directly bind to these two AML1-binding sites in electrophoretic mobility shift assay, but luciferase reporter assay revealed that the AML1 binding sites were not indispensable for Cx43 induction by AML1-ETO protein. Conversely, AP1 sites exerted an important role in this event. In agreement, AML1-ETO overexpression in leukemic U937 cells activated c-Jun N-terminal kinase (JNK), while its specific inhibitor SP600125 effectively abrogated AML1-ETO-induced Cx43 expression, indicating that JNK signaling pathway contributes to AML1-ETO induced Cx43 expression. These results would shed new insights for understanding mechanisms of AML1-ETO-associated leukemogenesis. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:505 / 511
页数:7
相关论文
共 27 条
[1]
Temporal gradient in sheer-induced signaling pathway:: involvement of MAP kinase, c-fos, and connexin43 [J].
Bao, XP ;
Clark, CB ;
Frangos, JA .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 278 (05) :H1598-H1605
[2]
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase [J].
Bennett, BL ;
Sasaki, DT ;
Murray, BW ;
O'Leary, EC ;
Sakata, ST ;
Xu, WM ;
Leisten, JC ;
Motiwala, A ;
Pierce, S ;
Satoh, Y ;
Bhagwat, SS ;
Manning, AM ;
Anderson, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13681-13686
[3]
Chen JT, 2003, CLIN CANCER RES, V9, P4200
[4]
The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner [J].
Elsässer, A ;
Franzen, M ;
Kohlmann, A ;
Weisser, M ;
Schnittger, S ;
Schoch, C ;
Reddy, VA ;
Burel, S ;
Zhang, DE ;
Ueffing, M ;
Tenen, DG ;
Hiddemann, W ;
Behre, G .
ONCOGENE, 2003, 22 (36) :5646-5657
[5]
Williams-Beuren syndrome critical region-5/non-T-cell activation linker:: a novel target gene of AML1/ETO [J].
Fliegauf, M ;
Stock, M ;
Berg, T ;
Lübbert, M .
ONCOGENE, 2004, 23 (56) :9070-9081
[6]
Frank R, 1995, ONCOGENE, V11, P2667
[7]
Fusion-protein truncation provides new insights into leukemogenesis [J].
Hess, JL ;
Hug, BA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (49) :16985-16986
[8]
Connexins as targets for cancer chemoprevention and chemotherapy [J].
King, TJ ;
Bertram, JS .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2005, 1719 (1-2) :146-160
[9]
The AML1/ETO fusion protein activates transcription of BCL-2 [J].
Klampfer, L ;
Zhang, J ;
Zelenetz, AO ;
Uchida, H ;
Nimer, SD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (24) :14059-14064
[10]
Koffler L, 2000, J CELL BIOCHEM, V79, P347, DOI 10.1002/1097-4644(20001201)79:3<347::AID-JCB10>3.0.CO